Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Allurion Technologies ( (ALUR) ) is now available.
On February 24, 2026, Allurion Technologies, Inc. entered into an inducement agreement with certain warrant holders to amend existing warrants issued in 2025 by cutting their exercise prices to $1.15 per share. In return, these investors agreed to exercise warrants for 2,659,565 shares of common stock for about $3.0 million in gross proceeds and received new five‑year warrants for up to 5,319,130 shares, subject to ownership caps of 4.99% or 9.99%.
The move strengthens Allurion’s near‑term liquidity while increasing potential future dilution, and underscores the company’s reliance on equity-linked financing to support its operations and growth plans. Allurion engaged Roth Capital Partners as financial advisor, agreeing to pay a 5% fee on gross proceeds plus up to $40,000 in expenses, and committed to register the resale of shares underlying the new warrants, signaling an effort to maintain access to capital markets for existing and prospective investors.
The most recent analyst rating on (ALUR) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Allurion Technologies stock, see the ALUR Stock Forecast page.
Spark’s Take on ALUR Stock
According to Spark, TipRanks’ AI Analyst, ALUR is a Neutral.
Overall score is held back primarily by weak financial performance: contracting revenue, large ongoing losses, heavy cash burn, and negative equity. Offsetting factors include improving cost control and constructive FDA/regulatory and balance-sheet restructuring progress discussed on the earnings call, plus moderately positive technical momentum. Valuation remains difficult to support due to negative earnings and no dividend yield provided.
To see Spark’s full report on ALUR stock, click here.
More about Allurion Technologies
Allurion Technologies, Inc. operates in the healthcare sector and is focused on medical technologies linked to weight management and related treatments, with its capital structure built around common stock and associated warrants. The company accesses equity markets through registered offerings and warrant issuances, targeting investors in growth-oriented healthcare and medical device businesses.
Average Trading Volume: 2,559,167
Technical Sentiment Signal: Sell
Current Market Cap: $16.7M
For detailed information about ALUR stock, go to TipRanks’ Stock Analysis page.